Alfredo Carrato Molecular Epidemiology and Predictive Tumor Markers Group, Area 3 Ramón y Cajal Health Research Institute (IRYCIS) Biography Publications Institution JoVE Articles Alfredo Carrato has not added a biography. If you are Alfredo Carrato and would like to personalize this page please email our Author Liaison for assistance. Publications Limited T Cell Response to SARS-CoV-2 MRNA Vaccine Among Patients with Cancer Receiving Different Cancer Treatments European Journal of Cancer (Oxford, England : 1990). May, 2022 | Pubmed ID: 35316750 Clinical Nutrition As Part of the Treatment Pathway of Pancreatic Cancer Patients: an Expert Consensus Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Jan, 2022 | Pubmed ID: 34363594 Phase I/II Trial of Sequential Treatment of Nab-paclitaxel in Combination with Gemcitabine Followed by Modified FOLFOX Chemotherapy in Patients with Untreated Metastatic Exocrine Pancreatic Cancer: Phase I Results European Journal of Cancer (Oxford, England : 1990). Nov, 2020 | Pubmed ID: 32977220 A Comprehensive Analysis of Candidate Genes in Familial Pancreatic Cancer Families Reveals a High Frequency of Potentially Pathogenic Germline Variants EBioMedicine. Mar, 2020 | Pubmed ID: 32113160 Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms International Journal of Molecular Sciences. Oct, 2019 | Pubmed ID: 31597249 First-line Single-agent Regorafenib in Frail Patients with Metastatic Colorectal Cancer: a Pilot Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) BMC Cancer. Jun, 2019 | Pubmed ID: 31159765 Targeting Tyrosine Kinases in Renal Cell Carcinoma: "New Bullets Against Old Guys" International Journal of Molecular Sciences. Apr, 2019 | Pubmed ID: 30999623 Novel Molecular Characterization of Colorectal Primary Tumors Based on MiRNAs Cancers. Mar, 2019 | Pubmed ID: 30862091 A Label Free Disposable Device for Rapid Isolation of Rare Tumor Cells from Blood by Ultrasounds Micromachines. Mar, 2018 | Pubmed ID: 30424062 First-line Panitumumab Plus FOLFOX4 or FOLFIRI in Colorectal Cancer with Multiple or Unresectable Liver Metastases: A Randomised, Phase II Trial (PLANET-TTD) European Journal of Cancer (Oxford, England : 1990). 08, 2017 | Pubmed ID: 28633089 Consensus Guidelines for Diagnosis, Treatment and Follow-up of Patients with Pancreatic Cancer in Spain Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Jun, 2017 | Pubmed ID: 27995549 Post-gemcitabine Therapy for Patients with Advanced Pancreatic Cancer - A Comparative Review of Randomized Trials Evaluating Oxaliplatin- And/or Irinotecan-containing Regimens Cancer Treatment Reviews. Nov, 2016 | Pubmed ID: 27676174 Erratum To: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a Genomic Resource for Functional Studies BMC Genomics. Nov, 2015 | Pubmed ID: 26621286 Circulating Tumor Cells (Ctc) and Kras Mutant Circulating Free Dna (cfdna) Detection in Peripheral Blood As Biomarkers in Patients Diagnosed with Exocrine Pancreatic Cancer BMC Cancer. Oct, 2015 | Pubmed ID: 26498594 The UBC-40 Urothelial Bladder Cancer Cell Line Index: a Genomic Resource for Functional Studies BMC Genomics. 05, 2015 | Pubmed ID: 25997541 Panitumumab and Irinotecan Every 3 weeks is an Active and Convenient Regimen for Second-line Treatment of Patients with Wild-type K-RAS Metastatic Colorectal Cancer Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Sep, 2013 | Pubmed ID: 23359181 Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: a Randomized, Phase III Trial Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Apr, 2013 | Pubmed ID: 23358972 Understanding the Molecular-based Mechanism of Action of the Tyrosine Kinase Inhibitor: Sunitinib Anti-cancer Drugs. Jan, 2010 | Pubmed ID: 20110785 Spanish Society of Medical Oncology Consensus for the Use of Haematopoietic Colony-stimulating Factors in Cancer Patients Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Jul, 2009 | Pubmed ID: 19574202 Capecitabine Plus Oxaliplatin for the Treatment of Colorectal Cancer Expert Review of Anticancer Therapy. Feb, 2008 | Pubmed ID: 18279056 Anti-VEGF Therapy: a New Approach to Colorectal Cancer Therapy Expert Review of Anticancer Therapy. Oct, 2006 | Pubmed ID: 17069524 Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 Ricerca sul cancro Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay Cristina Galindo-Pumariño1, Alberto Herrera2, Alberto Muñoz3, Alfredo Carrato1, Mercedes Herrera4, Cristina Peña1 1Medical Oncology Department, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERONC, 2Department of Medical Oncology, Hospital Universitario Puerta de Hierro de Majadahonda, 3Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid, CIBERONC, 4Department of Oncology & Pathology, Karolinska Institutet JoVE 60304 Ricerca sul cancro
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 Ricerca sul cancro
Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay Cristina Galindo-Pumariño1, Alberto Herrera2, Alberto Muñoz3, Alfredo Carrato1, Mercedes Herrera4, Cristina Peña1 1Medical Oncology Department, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERONC, 2Department of Medical Oncology, Hospital Universitario Puerta de Hierro de Majadahonda, 3Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid, CIBERONC, 4Department of Oncology & Pathology, Karolinska Institutet JoVE 60304 Ricerca sul cancro
